{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:14Z","timestamp":1792787834126,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Abbie Basson Sarcoma Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sarcomas are a heterogeneous group of malignancies arising from mesenchymal cells. Epidemiological studies on sarcoma from Australia are lacking, as previous studies have focused on a sarcoma type (e.g. soft tissue) or anatomical sites.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Linked cancer registry, hospital morbidity and death registration data were available for Western Australia (WA) from 1982 to 2016. All new sarcoma cases among WA residents were included to estimate incidence, prevalence, relative survival and cancer-related hospitalisation, using the Information Network on Rare Cancers (RARECARENet) definitions. To provide a reference point, comparisons were made with female breast, colorectal, prostate and lung cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>For 2012\u201316, the combined sarcoma crude annual incidence was 7.3 per 100,000, with the majority of these soft tissue sarcoma (STS, incidence of 5.9 per 100,000). The age-standardised incidence and prevalence of STS increased over time, while bone sarcoma remained more stable. Five-year relative survival for the period 2012\u201316 for STS was 65% for STS (higher than lung cancer, but lower than prostate, female breast and colorectal cancers), while five-year relative survival was 71% for bone sarcoma. Cancer-related hospitalisations cost an estimated $(Australian) 29.1 million over the study period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>STS incidence has increased over time in WA, with an increasing proportion of people diagnosed aged \u226565\u2009years. The analysis of health service use showed sarcoma had a lower mean episode of cancer-related hospitalisation compared to the reference cancers in 2016, but the mean cost per prevalent person was higher for sarcoma than for female breast, colorectal and prostate cancers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-07103-w","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T06:02:58Z","timestamp":1594015378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Sarcoma epidemiology and cancer-related hospitalisation in Western Australia from 1982 to 2016: a descriptive study using linked administrative data"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1145-947X","authenticated-orcid":false,"given":"Cameron M.","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4065-4044","authenticated-orcid":false,"given":"Georgia","family":"Halkett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2410-0239","authenticated-orcid":false,"given":"Richard","family":"Carey Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8742-7151","authenticated-orcid":false,"given":"Rachael","family":"Moorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,6]]},"reference":[{"key":"7103_CR1","volume-title":"Sarcoma statistics Canberra","author":"Cancer Australia","year":"2018","unstructured":"Cancer Australia. Sarcoma statistics Canberra. 2018. https:\/\/sarcoma.canceraustralia.gov.au\/statistics. Accessed 22 Jul 2019."},{"issue":"9","key":"7103_CR2","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/ans.14018","volume":"88","author":"RH Woods","year":"2018","unstructured":"Woods RH, Potter JA, Reid JL, Louise J, Bessen T, Farshid G, et al. Patterns of head and neck sarcoma in Australia. ANZ J Surg. 2018;88(9):901\u20136.","journal-title":"ANZ J Surg"},{"key":"7103_CR3","volume-title":"Childhood cancer in Australia, 1983\u20132015","author":"DR Youlden","year":"2019","unstructured":"Youlden DR, Aitken JF. Childhood cancer in Australia, 1983\u20132015. Brisbane: Cancer Council Queensland; 2019."},{"issue":"4","key":"7103_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1080\/00313020500168737","volume":"37","author":"JB Blackwell","year":"2005","unstructured":"Blackwell JB, Threlfall TJ, McCaul KA. Primary malignant bone tumours in Western Australia, 1972-1996. Pathology. 2005;37(4):278\u201383.","journal-title":"Pathology"},{"key":"7103_CR5","doi-asserted-by":"crossref","unstructured":"Gibson E, Woods RH, Potter JA, et al. Epidemiological trends in dermal sarcoma in Australia. Australas J Plast Surg. 2019;2(2):10\u20136.","DOI":"10.34239\/ajops.v2n2.127"},{"key":"7103_CR6","doi-asserted-by":"publisher","first-page":"101590","DOI":"10.1016\/j.canep.2019.101590","volume":"63","author":"T Bessen","year":"2019","unstructured":"Bessen T, Caughey GE, Shakib S, Potter JA, Reid J, Farshid G, et al. A population-based study of soft tissue sarcoma incidence and survival in Australia: an analysis of 26,970 cases. Cancer Epidemiol. 2019;63:101590.","journal-title":"Cancer Epidemiol"},{"key":"7103_CR7","volume-title":"Department of Health. Clinical Trial Activity: Rare Cancers and Rare Diseases and Unmet Needs","author":"Australian Government","year":"2019","unstructured":"Australian Government: Department of Health. Clinical Trial Activity: Rare Cancers and Rare Diseases and Unmet Needs. 2019. https:\/\/www.health.gov.au\/initiatives-and-programs\/clinical-trial-activity-rare-cancers-and-rare-diseases-and-unmet-needs. Accessed 24 Sept 2019."},{"issue":"10","key":"7103_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001885","volume":"12","author":"EI Benchimol","year":"2015","unstructured":"Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The REporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 2015;12(10):e1001885.","journal-title":"PLoS Med"},{"issue":"5","key":"7103_CR9","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1467-842X.1999.tb01297.x","volume":"23","author":"CD Holman","year":"1999","unstructured":"Holman CD, Bass AJ, Rouse IL, Hobbs MS. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health. 1999;23(5):453\u20139.","journal-title":"Aust N Z J Public Health"},{"key":"7103_CR10","unstructured":"Australian Bureau of Statistics. 3101.0. Australian Demographic Statistics, Sep 2018. Table 4. Estimated Resident Population, States and Territories (Number). 2018. https:\/\/www.abs.gov.au\/AUSSTATS\/abs@.nsf\/DetailsPage\/3101.0Sep%202018?OpenDocument. Accessed 24 Apr 2019."},{"key":"7103_CR11","volume-title":"International rules for multiple primary cancers","author":"International Association of Cancer Registries","year":"2004","unstructured":"International Association of Cancer Registries. International rules for multiple primary cancers. 2004. http:\/\/www.iacr.com.fr\/images\/doc\/MPrules_july2004.pdf. Accessed 3 Feb 2020."},{"key":"7103_CR12","volume-title":"Cancer survival and prevalence in Australia: period estimates from 1982 to 2010. Cancer Series no. 69. Cat. no. CAN 65","author":"Australian Institute of Health and Welfare","year":"2012","unstructured":"Australian Institute of Health and Welfare. Cancer survival and prevalence in Australia: period estimates from 1982 to 2010. Cancer Series no. 69. Cat. no. CAN 65. Canberra, Australian Capital Territory: Australian Institute of Health and Welfare; 2012."},{"key":"7103_CR13","volume-title":"List of rare cancers","author":"Information Network on Rare Cancers","year":"2015","unstructured":"Information Network on Rare Cancers. List of rare cancers. 2015. http:\/\/www.rarecarenet.eu\/rarecarenet\/index.php\/cancerlist. Accessed 27 Aug 2019."},{"issue":"8","key":"7103_CR14","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/S1470-2045(17)30445-X","volume":"18","author":"G Gatta","year":"2017","unstructured":"Gatta G, Capocaccia R, Botta L, et al. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. Lancet Oncol. 2017;18(8):1022\u201339.","journal-title":"Lancet Oncol"},{"key":"7103_CR15","volume-title":"Age-adjusted incidence over time in Europe","author":"Information Network on Rare Cancers","year":"2020","unstructured":"Information Network on Rare Cancers. Age-adjusted incidence over time in Europe. 2020. http:\/\/www.rarecarenet.eu\/analysis.php. Accessed 6 Feb 2020."},{"issue":"1","key":"7103_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12963-014-0033-x","volume":"12","author":"S Maxwell","year":"2014","unstructured":"Maxwell S, O'Leary P, Slevin T, et al. The increase in cancer prevalence and hospital burden in Western Australia, 1992-2011. Popul Health Metrics. 2014;12(1):33.","journal-title":"Popul Health Metrics"},{"key":"7103_CR17","volume-title":"Methodological note no. 10, end results evaluation section. Instructions to IBM 650 programmers in processing survival computations","author":"FH Ederer","year":"1959","unstructured":"Ederer FH, H. Methodological note no. 10, end results evaluation section. Instructions to IBM 650 programmers in processing survival computations. Bethesda: National Cancer Institute; 1959."},{"issue":"2","key":"7103_CR18","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/ije\/31.2.456","volume":"31","author":"H Brenner","year":"2002","unstructured":"Brenner H, Soderman B, Hakulinen T. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. Int J Epidemiol. 2002;31(2):456\u201362.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"7103_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/1753-6405.12610","volume":"40","author":"P Baade","year":"2016","unstructured":"Baade P, Cramb S, Dasgupta P, Youlden D. Estimating cancer survival - improving accuracy and relevance. Aust N Z J Public Health. 2016;40(5):403\u20134.","journal-title":"Aust N Z J Public Health"},{"key":"7103_CR20","volume-title":"1, 3 and 5-year Relative Survival (RS) overtime in Europe","author":"Information Network on Rare Cancers","year":"2020","unstructured":"Information Network on Rare Cancers. 1, 3 and 5-year Relative Survival (RS) overtime in Europe. 2020. http:\/\/www.rarecarenet.eu\/analysis.php. Accessed 6 Feb 2020."},{"key":"7103_CR21","volume-title":"Deaths, Year of registration, Age at death, Age-specific death rates, Sex, States, Territories and Australia","author":"Australian Bureau of Statistics","year":"2016","unstructured":"Australian Bureau of Statistics. Deaths, Year of registration, Age at death, Age-specific death rates, Sex, States, Territories and Australia. 2016. https:\/\/www.abs.gov.au\/?QueryId=1324#. Accessed 3 Feb 2020."},{"key":"7103_CR22","volume-title":"National Efficient Price Determination","author":"Independent Hospitals Pricing Authority","year":"2020","unstructured":"Independent Hospitals Pricing Authority. National Efficient Price Determination. 2020. https:\/\/www.ihpa.gov.au\/what-we-do\/national-efficient-price-determination. Accessed 24 Apr 2020."},{"key":"7103_CR23","volume-title":"Tables 1 and 2. CPI: All Groups, Index Numbers and Percentage Changes","author":"Australian Bureau of Statistics","year":"2019","unstructured":"Australian Bureau of Statistics. Tables 1 and 2. CPI: All Groups, Index Numbers and Percentage Changes. 2019. https:\/\/www.abs.gov.au\/AUSSTATS\/abs@.nsf\/DetailsPage\/6401.0Mar%202019?OpenDocument. Accessed 13 Sept 2019."},{"issue":"12","key":"7103_CR24","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1002\/ijc.22239","volume":"119","author":"JR Toro","year":"2006","unstructured":"Toro JR, Travis LB, Wu HJ, Zhu K, Fletcher CD, Devesa SS. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26,758 cases. Int J Cancer. 2006;119(12):2922\u201330.","journal-title":"Int J Cancer"},{"issue":"6","key":"7103_CR25","first-page":"310","volume":"50","author":"J Pike","year":"2008","unstructured":"Pike J, Clarkson PW, Masri BA. Soft tissue sarcomas of the extremities: how to stay out of trouble. B C Med. 2008;50(6):310\u20138.","journal-title":"B C Med"},{"key":"7103_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13569-016-0060-4","volume":"6","author":"A Dangoor","year":"2016","unstructured":"Dangoor A, Seddon B, Gerrand C, Grimer R, Whelan J, Judson I. UK guidelines for the management of soft tissue sarcomas. Clin Sarcoma Res. 2016;6:20.","journal-title":"Clin Sarcoma Res"},{"key":"7103_CR27","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3389\/fonc.2019.00662","volume":"9","author":"B Pingping","year":"2019","unstructured":"Pingping B, Yuhong Z, Weiqi L, Chunxiao W, Chunfang W, Yuanjue S, et al. Incidence and mortality of sarcomas in Shanghai, China, during 2002-2014. Front Oncol. 2019;9:662.","journal-title":"Front Oncol"},{"issue":"1","key":"7103_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12889-018-5131-4","volume":"18","author":"M Ressing","year":"2018","unstructured":"Ressing M, Wardelmann E, Hohenberger P, Jakob J, Kasper B, Emrich K, et al. Strengthening health data on a rare and heterogeneous disease: sarcoma incidence and histological subtypes in Germany. BMC Public Health. 2018;18(1):235.","journal-title":"BMC Public Health"},{"key":"7103_CR29","volume-title":"Clinical Trials and Studies: Advanced Soft Tissue Sarcoma Study","author":"Australian and New Zealand Sarcoma Association","year":"2020","unstructured":"Australian and New Zealand Sarcoma Association. Clinical Trials and Studies: Advanced Soft Tissue Sarcoma Study. 2020. https:\/\/www.sarcoma.org.au\/projects. Accessed 19 Feb 2020."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07103-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07103-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07103-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T19:33:21Z","timestamp":1625513601000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07103-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,6]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7103"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07103-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,6]]},"assertion":[{"value":"10 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the WA Department of Health Human Research Ethics Committee (2012\/42), which exempted the study from obtaining individual patient consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable, as per statement above.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"625"}}